PRISM Logistics to Sponsor CSCMP San Francisco Lunch

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
PRISM Logistics to Sponsor CSCMP San Francisco Lunch Collaboration with BioSupply Management Alliance (BSMA) THURSDAY Oct. 20th

SAN FRANCISCO, CA--(Marketwired - Oct 17, 2016) - PRISM Logistics has been announced as the luncheon keynote and panel discussion sponsor for the upcoming CSCMP / Bio Supply Management Alliance (BSMA) collaboration event titled "Preparing the Biotech Supply Chain for 2025 - Move It Don't Lose It!". The daylong biotechnology supply chain conference takes place on October 20 th at the Crowne Plaza Hotel in Foster City, CA.

Said CSCMP SFRT president, Michele Carroll, "Biotech, pharma, health and med tech are such important market sectors, historically underserved by our non-profit. Our Roundtable is excited to partner again this year with BSMA on this highly regarded forum for discussion of trends, issues and innovations in this space. We're grateful to PRISM Logistics for its generous sponsorship and to Mark Buck of Bio-Rad Laboratories for chairing the CSCMP Luncheon anchoring the full day of sessions."

The event luncheon runs from noon to 2 p.m. and features a keynote presentation by Sean Monahan , Partner, A.T. Kearney , discussing highlights and trends from the recently released 27th Annual CSCMP State of Logistics Report®. The report includes a focused narrative on the economic environment impacting logistics; insights from interviews with industry leaders, including shippers, carriers, and analysts; a spotlight on relevant trends; and a strategic point of view on the state of the industry.

Mr. Monahan will then moderate a panel discussion (and dynamic audience interaction) titled, "Move It, Don't Lose It!" exploring potential impacts of globalization, Industry 4.0 and Brexit on biotech and pharma supply chains, and a look forward through the next decade. Panelists are Franck Toussaint , Managing Director, Biolog Europe and Horacio Enriquez , Sr. Manager, Bio-Rad Laboratories .

To register for either the full day or just the luncheon, go to: http://www.cscmpsfrt.org/event-2340866 .

About CSCMP and CSCMP San Francisco Roundtable Serving 8500+ members worldwide, the Council of Supply Chain Management Professionals ( www.cscmp.org ) is a non-profit membership association that helps supply chain managers and executives connect, collaborate and become more effective professionals. One of the most dynamic of its 82 Roundtables around the globe, the San Francisco CSCMP provides regular educational events, networking opportunities and a scholarship program. For more information, please visit www.cscmpsfrt.org .

Contact: Michele Carroll Email Contact 925-980-1767

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 4

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 5

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 3

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 3

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 7

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 3

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 2

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading

Top 5 Most Recently Viewed Articles

Tilray Brands Achieves Exceptional Performance in Q1 2025

Updated Category News Views 226

Tilray Brands Delivers Record Q1 Revenue Tilray Brands (NASDAQ: TLRY) has announced an impressive net revenue of $200 million for its first fiscal quarter, showcasing a remarkable 13% increase from the previous year. The significant boost can largely be attributed to the exponential growth within its beverage sector, including both traditional craft beers and innovative...

Continue Reading
Exor N.V. Announces Impressive Growth and Strategic Moves

Updated Category News Views 361

Exor N.V. Reports Robust Year-End Performance Exor N.V. has once again demonstrated significant growth and strategic financial management through its latest annual results. The company reported an impressive 9% growth in Net Asset Value (NAV) per share for the fiscal year, reaching €38.2 billion by year-end. This financial achievement reflects Exor's robust operational...

Continue Reading
Integral Ad Science Faces Legal Challenge – Join the Action

Updated Category News Views 102

Integral Ad Science Holding Corp. Faces Securities Fraud Allegations Levi & Korsinsky, LLP is reaching out to the investors of Integral Ad Science Holding Corp. (NASDAQ: IAS), as there is an ongoing class action securities lawsuit that could allow affected investors to recover losses. Understanding the Class Action Details This class action lawsuit aims to represent those...

Continue Reading
Innovative Oncology Solutions Unveiled by Powered Research

Updated Category News Views 132

Expanding Horizons: Powered Research's New Oncology Services For over a decade, Powered Research has earned its reputation as a premier preclinical contract research organization (CRO), particularly in the field of ophthalmology. Today, the company takes a monumental step forward by launching an extensive suite of oncology preclinical services. This new direction is set...

Continue Reading
Discover Why Jim Cramer Recommends Dominion Energy Stock

Updated Category News Views 65

Jim Cramer Sees Potential in Dominion Energy In a recent episode of CNBC's programming, well-known financial commentator Jim Cramer highlighted Dominion Energy, Inc. (D) as a promising buy. He stated, "We need cheap power," which underscores the increasing demand for affordable energy solutions in today's unpredictable market landscape. Analyst Ratings for Dominion Energy...

Continue Reading